Literature DB >> 27222925

Novel pathologic findings in patients with Pelizaeus-Merzbacher disease.

Jeremy J Laukka1, John Kamholz2, Denise Bessert3, Robert P Skoff4.   

Abstract

Pelizaeus-Merzbacher disease (PMD) is an X-linked inherited hypomyelinating disorder caused by mutations in the gene encoding proteolipid protein (PLP), the major structural protein in central nervous system (CNS) myelin. Prior to our study, whether hypomyelination in PMD was caused by demyelination, abnormally thin sheaths or failure to form myelin was unknown. In this study, we compared the microscopic pathology of myelin from brain tissue of 3 PMD patients with PLP1 duplications to that of a patient with a complete PLP1 deletion. Autopsy tissue procured from PMD patients was embedded in paraffin for immunocytochemistry and plastic for electron microscopy to obtain highresolution fiber pathology of cerebrum and corpus callosum. Through histological stains, immunocytochemistry and electron microscopy, our study illustrates unique pathologic findings between the two different types of mutations. Characteristic of the patient with a PLP1 deletion, myelin sheaths showed splitting and decompaction of myelin, confirming for the first time that myelin in PLP1 deletion patients is similar to that of rodent models with gene deletions. Myelin thickness and g-ratios of some fibers, in relation to axon diameter was abnormally thin, suggesting that oligodendrocytes remain metabolically functional and/or are attempting to make myelin. Many fibers showed swollen, progressive degenerative changes to axons in addition to the dissolution of myelin. All three duplication cases shared remarkable fiber pathology including swellings, constriction and/or transection and involution of myelin. Characteristic of PLP1 duplication patients, many axons showed segmental demyelination along their length. Still other axons had abnormally thick myelin sheaths, suggestive of continued myelination. Thus, each type of mutation exhibited unique pathology even though commonality to both mutations included involution of myelin, myelin balls and degeneration of axons. This pathology study describes findings unique to each mutation that suggests the mechanism causing fiber pathology is likewise heterogeneous.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Electron microscopy; Hypomyelination; Immunocytochemistry; Myelin and axon pathology; Pelizaeus-Merzbacher disease; Proteolipid protein

Mesh:

Substances:

Year:  2016        PMID: 27222925      PMCID: PMC4948744          DOI: 10.1016/j.neulet.2016.05.028

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  62 in total

Review 1.  Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease.

Authors:  C Bjartmar; J R Wujek; B D Trapp
Journal:  J Neurol Sci       Date:  2003-02-15       Impact factor: 3.181

2.  The contributions of myelin and axonal caliber to transverse relaxation time in shiverer and neurofilament-deficient mouse models.

Authors:  Victor V Dyakin; Yuanxin Chen; Craig A Branch; Aidong Yuan; Mala Rao; Asok Kumar; Corrinne M Peterhoff; Ralph A Nixon
Journal:  Neuroimage       Date:  2010-03-11       Impact factor: 6.556

3.  Jimpy(msd) mouse mutation and connatal Pelizaeus-Merzbacher disease.

Authors:  T Yamamoto; E Nanba; H Zhang; M Sasaki; H Komaki; K Takeshita
Journal:  Am J Med Genet       Date:  1998-02-03

4.  Magnetic resonance imaging pattern recognition in hypomyelinating disorders.

Authors:  Marjan E Steenweg; Adeline Vanderver; Susan Blaser; Alberto Bizzi; Tom J de Koning; Grazia M S Mancini; Wessel N van Wieringen; Frederik Barkhof; Nicole I Wolf; Marjo S van der Knaap
Journal:  Brain       Date:  2010-10       Impact factor: 13.501

5.  Axonal dysfunction and disability in a relapse of multiple sclerosis: longitudinal study of a patient.

Authors:  N De Stefano; P M Matthews; S Narayanan; G S Francis; J P Antel; D L Arnold
Journal:  Neurology       Date:  1997-10       Impact factor: 9.910

6.  The unfolded protein response modulates disease severity in Pelizaeus-Merzbacher disease.

Authors:  Cherie M Southwood; James Garbern; Wei Jiang; Alexander Gow
Journal:  Neuron       Date:  2002-11-14       Impact factor: 17.173

7.  Akt signals through the mammalian target of rapamycin pathway to regulate CNS myelination.

Authors:  S Priyadarshini Narayanan; Ana I Flores; Feng Wang; Wendy B Macklin
Journal:  J Neurosci       Date:  2009-05-27       Impact factor: 6.167

8.  Eme1 is involved in DNA damage processing and maintenance of genomic stability in mammalian cells.

Authors:  Jacinth Abraham; Bénédicte Lemmers; M Prakash Hande; Mary Ellen Moynahan; Charly Chahwan; Alberto Ciccia; Jeroen Essers; Katsuhiro Hanada; Richard Chahwan; Aik Kia Khaw; Peter McPherson; Amro Shehabeldin; Rob Laister; Cheryl Arrowsmith; Roland Kanaar; Stephen C West; Maria Jasin; Razqallah Hakem
Journal:  EMBO J       Date:  2003-11-17       Impact factor: 11.598

9.  Myelination in the jimpy mouse in the absence of proteolipid protein.

Authors:  I D Duncan; J P Hammang; S Goda; R H Quarles
Journal:  Glia       Date:  1989       Impact factor: 7.452

10.  Disrupted proteolipid protein trafficking results in oligodendrocyte apoptosis in an animal model of Pelizaeus-Merzbacher disease.

Authors:  A Gow; C M Southwood; R A Lazzarini
Journal:  J Cell Biol       Date:  1998-02-23       Impact factor: 10.539

View more
  14 in total

1.  Decreased number and increased volume with mitochondrial enlargement of cerebellar synaptic terminals in a mouse model of chronic demyelination.

Authors:  Huy Bang Nguyen; Yang Sui; Truc Quynh Thai; Kazuhiro Ikenaka; Toshiyuki Oda; Nobuhiko Ohno
Journal:  Med Mol Morphol       Date:  2018-05-23       Impact factor: 2.309

2.  Modeling the Mutational and Phenotypic Landscapes of Pelizaeus-Merzbacher Disease with Human iPSC-Derived Oligodendrocytes.

Authors:  Zachary S Nevin; Daniel C Factor; Robert T Karl; Panagiotis Douvaras; Jeremy Laukka; Martha S Windrem; Steven A Goldman; Valentina Fossati; Grace M Hobson; Paul J Tesar
Journal:  Am J Hum Genet       Date:  2017-03-30       Impact factor: 11.025

3.  Slow-gamma frequencies are optimally guarded against effects of neurodegenerative diseases and traumatic brain injuries.

Authors:  Pedro D Maia; Ashish Raj; J Nathan Kutz
Journal:  J Comput Neurosci       Date:  2019-06-04       Impact factor: 1.621

4.  Reaction time impairments in decision-making networks as a diagnostic marker for traumatic brain injuries and neurological diseases.

Authors:  Pedro D Maia; J Nathan Kutz
Journal:  J Comput Neurosci       Date:  2017-04-10       Impact factor: 1.621

5.  Auditory function in Pelizaeus-Merzbacher disease.

Authors:  Thierry Morlet; Kyoko Nagao; S Charles Bean; Sara E Mora; Sarah E Hopkins; Grace M Hobson
Journal:  J Neurol       Date:  2018-05-03       Impact factor: 4.849

6.  Insertion of proteolipid protein into mitochondria but not DM20 regulates metabolism of cells.

Authors:  Mallika Somayajulu; Denise A Bessert; Maik Hüttemann; Jasloveleen Sohi; John Kamholz; Robert P Skoff
Journal:  Neurosci Lett       Date:  2018-05-02       Impact factor: 3.046

7.  The wmN1 Enhancer Region of the Mouse Myelin Proteolipid Protein Gene (mPlp1) is Indispensable for Expression of an mPlp1-lacZ Transgene in Both the CNS and PNS.

Authors:  Pankaj Patyal; Neriman T Kockara; Patricia A Wight
Journal:  Neurochem Res       Date:  2019-11-28       Impact factor: 3.996

8.  Daam2 Regulates Myelin Structure and the Oligodendrocyte Actin Cytoskeleton through Rac1 and Gelsolin.

Authors:  Carlo D Cristobal; Chih-Yen Wang; Zhongyuan Zuo; Joshua A Smith; Aaron Lindeke-Myers; Hugo J Bellen; Hyun Kyoung Lee
Journal:  J Neurosci       Date:  2022-01-31       Impact factor: 6.709

Review 9.  Leukodystrophies: a proposed classification system based on pathological changes and pathogenetic mechanisms.

Authors:  Marjo S van der Knaap; Marianna Bugiani
Journal:  Acta Neuropathol       Date:  2017-06-21       Impact factor: 17.088

Review 10.  Effects of Intron 1 Sequences on Human PLP1 Expression: Implications for PLP1-Related Disorders.

Authors:  Patricia A Wight
Journal:  ASN Neuro       Date:  2017 Jul-Aug       Impact factor: 4.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.